In this article, we explore the mechanisms of resistance to targeted inhibitors, focusing on the interaction between the paracrine renin–angiotensin system within the melanoma TME and the Ras/RAF/MAPK/ERK and PI3K/AKT/mTOR pathways, as well as the role of CSCs regulated by these pathways. Here, MTOR is linked to melanoma.